The entry is based on a second-stage cup with handle .
[ibd-display-video id=2102289 width=50 float=left autostart=true] Understand that buying a stock just ahead of earnings can be risky since you typically don't have enough time to build a profit cushion before the latest quarterly numbers come out. Be sure to follow sound buy and sell rules to minimize your exposure.
The company reported 19% earnings-per-share growth in its most recent report. Sales increased 20%.
Analysts expect earnings-per-share growth of 10% for the quarter, and 17% growth for the full year. Annual growth estimates were recently revised higher.
The company has a 95 Composite Rating and holds the No. 3 rank among its peers in the Computer Software-Medical industry group. Tabula Rasa Healthcare ( TRHC ) is the No. 1-ranked stock within the group.
Note: Dates for earnings reports are subject to change. Check the company's website for any updates.